Dr Reddys launches generic oral anti-epileptic drug in US

Drug firm Dr Reddys Laboratories on Tuesday said it has launched generic anti-epileptic Vigabatrin powder for oral solution in the US market. The product is a generic version of Lundbecks Sabril powder for oral solution, Dr Reddys said in a filing to the BSE. The company has launched Vigabatrin powder for oral solution, USP in 500 mg per packet after getting approval by the United States Food and Drug Administration (USFDA), it said.

Upload Company Info



Chemxpert Demo Video


Dataset Sample


Chemical Name

Synonyms

Molecular Formula

Molecular Weight


To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Innovator

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Market Status

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Indication

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Therapeutic Segment

To Access this information please pay by using "Pay & Download" button.

Pay & Download

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Thank you for your enquiry

Your product will be updated soon in our database


Submit Your Query



Select Any Option



Page loaded in 0.001170 seconds